Our study highlights the prognostic value of LINC00173 in NPC, and identifies the LINC00173‐RAB1B‐PA2G4/SDF4 axis as a potential therapeutic target for NPC patients. This evidence concerns the gene SDF4 and nasopharyngeal carcinoma.